Therefore, Gyp are capable of regulating the lipid metabolic pathways by upregulating FXR expression, which can ultimately lead to an improvement in lipid metabolism in NAFLD. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.